These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 22930407

  • 1. Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia.
    Fillatre P, Chevrier S, Revest M, Gacouin A, Jouneau S, Leroy H, Robert-Gangneux F, Minjolle S, Le Tulzo Y, Tattevin P.
    Eur J Clin Microbiol Infect Dis; 2013 Feb; 32(2):189-94. PubMed ID: 22930407
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia.
    Lee S, Park Y, Kim SG, Ko EJ, Chung BH, Yang CW.
    Microbiol Immunol; 2020 May; 64(5):356-365. PubMed ID: 31994768
    [Abstract] [Full Text] [Related]

  • 6. Cytomegalovirus detection is associated with ICU admission in non-AIDS and AIDS patients with Pneumocystis jirovecii pneumonia.
    Perret A, Le Marechal M, Germi R, Maubon D, Garnaud C, Noble J, Boignard A, Falque L, Meunier M, Gerster T, Epaulard O.
    PLoS One; 2024 May; 19(1):e0296758. PubMed ID: 38198473
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19.
    Boers LS, van Someren Gréve F, van Hattem JM, de Brabander J, Zwaan T, van Willigen H, Cornelissen M, de Jong M, van der Poll T, Duitman J, Schinkel J, Bos LDJ, and the OPPORTUNE consortium, the Amsterdam UMC COVID study group, the ArtDECO consortium.
    Intensive Care Med; 2024 Aug; 50(8):1251-1264. PubMed ID: 39017695
    [Abstract] [Full Text] [Related]

  • 9. Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study.
    Gaborit BJ, Tessoulin B, Lavergne RA, Morio F, Sagan C, Canet E, Lecomte R, Leturnier P, Deschanvres C, Khatchatourian L, Asseray N, Garret C, Vourch M, Marest D, Raffi F, Boutoille D, Reignier J.
    Ann Intensive Care; 2019 Nov 27; 9(1):131. PubMed ID: 31776705
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pneumocystis jirovecii pneumonia in children. A retrospective study in a single center over three decades.
    García-Moreno J, Melendo-Pérez S, Martín-Gómez MT, Frick MA, Balcells-Ramírez J, Pujol-Jover M, Martín-Nalda A, Mendoza-Palomar N, Soler-Palacín P.
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Mar 27; 38(3):111-118. PubMed ID: 31272810
    [Abstract] [Full Text] [Related]

  • 13. Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy.
    Miller RF, Allen E, Copas A, Singer M, Edwards SG.
    Thorax; 2006 Aug 27; 61(8):716-21. PubMed ID: 16601092
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cytomegalovirus in the bronchoalveolar lavage fluid of patients with AIDS.
    Miles PR, Baughman RP, Linnemann CC.
    Chest; 1990 May 27; 97(5):1072-6. PubMed ID: 2158878
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Assessment of cytomegalovirus and cell-mediated immunity for predicting outcomes in non-HIV-infected patients with Pneumocystis jirovecii pneumonia.
    Kim T, Park SY, Lee HJ, Kim SM, Sung H, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH.
    Medicine (Baltimore); 2017 Jul 27; 96(30):e7243. PubMed ID: 28746178
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the performance of DiaSorin molecular Pneumocystis jirovecii-CMV multiplex real-time PCR assay from bronchoalveolar lavage samples.
    Kilic A, Elliott S, Hester L, Palavecino E.
    J Mycol Med; 2020 Jun 27; 30(2):100936. PubMed ID: 32044156
    [Abstract] [Full Text] [Related]

  • 20. Prognostic implication of bronchoalveolar lavage fluid analysis in patients with Pneumocystis jirovecii pneumonia without human immunodeficiency virus infection.
    Chung C, Lim CM, Oh YM, Hong SB, Choi CM, Huh JW, Lee SW, Lee JS, Jo KW, Ji W, Park CJ, Kim M, Sung H, Cho YU, Cho HS, Kim HC.
    BMC Pulm Med; 2022 Jun 26; 22(1):251. PubMed ID: 35754032
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.